In an era when digital tools promise to decode the rhythms of the body, researchers writing in The BMJ are urging a pause — not against curiosity about menstrual health, but against the confidence with which apps and cycle-syncing practices have outrun the science that might justify them. Katharine Lee and colleagues find that decades of sports science reveal no meaningful cycle-phase effect on performance or injury, and that the data these apps collect carries real risks to privacy and autonomy. The warning is less a rejection of women's health technology than a call to hold it to the same ev
Menstrual tracking apps lack scientific evidence, pose privacy risks
The evidence that these tools can actually help is lacking
Mark
So these apps are just making things up? Are they lying about the science?
Mimi
Not exactly lying, but marketing claims that outpace what the research supports. The apps say they can optimize your performance or health based on your cycle. The actual science shows menstrual cycle effects on performance are either nonexistent or so small and individual that no app can reliably predict them.
Luke
But wait—some people do feel different at different points in their cycle. Isn't that real?
Mimi
Absolutely real for some people. The problem is it's highly individual and inconsistent. What the researchers are saying is that a one-size-fits-all app can't capture that variation reliably.
Mark
What about the data privacy angle? How bad is it?
Mimi
Menstrual data is sensitive health information. These apps collect it, and there's no guarantee it's protected. It could be breached, sold, or accessed by employers. That's a concrete risk.
Luke
Do we know if that's actually happened? Or is it a theoretical risk?
Mimi
The researchers identify it as a risk in the current regulatory environment. I don't see evidence in the source that breaches have occurred, but the vulnerability exists.
Mark
So what should someone do if they're already using one of these apps?
Mimi
The researchers aren't saying throw them away. They're saying regulators need to set standards, clinicians should only recommend apps that meet those standards, and users should know what data they're sharing and why.
Luke
And if someone finds that tracking their cycle actually helps them? Should they stop?
Mimi
No. But they should know the app's claims aren't backed by broad scientific evidence, and they should be cautious about what personal data they're feeding into it.
El Pulso
- Menstrual tracking apps have proliferated across social media with polished, science-adjacent marketing that far outpaces the actual research supporting their claims.
- Sports science finds no reliable overall link between cycle phase and athletic performance, and dietary interventions tied to cycle syncing remain inconclusive and deeply individual.
- The apps themselves lack the technological sophistication to accurately predict the very hormonal variations they promise to optimize — making the core product unreliable even if the underlying biology were settled.
- Sensitive menstrual data sits in poorly protected commercial environments, raising urgent concerns about breaches, employer surveillance, and the exploitation of feminist language to build unearned trust.
- Researchers are calling on regulators to tighten data protections, on clinicians to withhold recommendations until apps meet rigorous standards, and on public health communicators to meet women on the social media platforms where this misinformation spreads.
In an era when digital tools promise to decode the rhythms of the body, researchers writing in The BMJ are urging a pause — not against curiosity about menstrual health, but against the confidence with which apps and cycle-syncing practices have outrun the science that might justify them. Katharine Lee and colleagues find that decades of sports science reveal no meaningful cycle-phase effect on performance or injury, and that the data these apps collect carries real risks to privacy and autonomy. The warning is less a rejection of women's health technology than a call to hold it to the same evidentiary standards we would demand of any other medical claim.
A warning published in The BMJ this week from researcher Katharine Lee and colleagues targets a quiet but widespread phenomenon: menstrual tracking apps and the practice of cycle syncing, which have become fixtures of social media wellness culture despite a notably thin scientific foundation. These tools promise that monitoring cycle phase can help women optimize diet, exercise, and performance — a pitch that sounds plausible but, on examination, lacks convincing support.
Decades of sports science research show no meaningful overall effect of menstrual cycle phase on athletic performance or injury risk. Where effects have been detected, they are small and highly individual, making population-level guidance unreliable. Research on dietary adjustments tied to cycle phase is similarly inconclusive. Compounding the weak evidence is a technological gap: even if cycle phases did reliably predict health changes in a given person, current apps are not sophisticated enough to detect those variations accurately.
The risks the researchers identify go beyond ineffectiveness. Menstrual data is sensitive health information collected in a consumer environment with weak protections, leaving users vulnerable to breaches and, in some workplace contexts, unwanted surveillance. There is also an opportunity cost — attention devoted to unproven apps could instead support evidence-based care — and a subtler harm in the way some apps deploy the language of empowerment and bodily autonomy to build trust that the underlying science does not warrant.
The researchers stop short of calling for prohibition. Instead, they urge regulators to strengthen data protections and demand transparency, ask clinicians to recommend only apps that meet rigorous scientific standards, and propose that credible health messaging be built directly into the social media spaces where cycle syncing is most actively promoted. The apps are not disappearing, but the researchers argue the conversation about what they can genuinely offer — and at what cost — is long overdue.
A warning arrived in The BMJ this week from researchers who have grown concerned about the gap between what menstrual tracking apps promise and what the science actually supports. Katharine Lee and her colleagues are raising an alarm about tools that have become ubiquitous on social media and in app stores—digital platforms marketed directly to women and girls with claims that they can scientifically analyze personal cycle data to enhance health, wellbeing, and athletic performance. The pitch is sleek and confident. The evidence, they argue, is not.
The practice these apps promote goes by several names: menstrual tracking, cycle syncing, or phase-based optimization. The idea is straightforward enough—that by monitoring where a person is in their menstrual cycle, they can adjust diet and exercise accordingly to maximize performance or minimize symptoms. It sounds reasonable. It sounds scientific. But when Lee's team examined the research literature, they found something closer to a house built on sand. Decades of sports science research, they note, shows no meaningful overall effect of menstrual cycle phase on athletic performance, injury risk, or general health. Where small effects have been detected, they tend to be trivial and highly individual—meaning what works for one person may mean nothing for another. Research on whether adjusting diet based on cycle phase actually reduces menstrual symptoms or improves performance is similarly inconclusive, highly variable from person to person, or simply speculative.
Beyond the weak evidence base lies a more fundamental problem: even if menstrual phases did reliably correspond with changes in health or vulnerability to injury in a given individual, the apps themselves cannot dependably predict those variations. The technology is not sophisticated enough for the claims being made. Yet the marketing is sophisticated indeed. The researchers point out that the slick promotion of these tools and the scientifically questionable practice of cycle syncing demand what they call "critical interrogation and resistance." In other words, skepticism.
The harms extend beyond wasted money or time spent logging data that may not matter. Lee and colleagues identify several concrete risks. There is the question of data privacy—menstrual information is sensitive health data, and the apps collecting it operate in an environment where consumer protections remain weak and data breaches are common. There is the risk of unwanted surveillance, particularly in workplaces where employers might gain access to cycle information. There is the opportunity cost: time and attention spent on apps with no proven benefit could be redirected toward evidence-based approaches to menstrual health. And there is a subtler harm: these apps may distract from or actively undermine genuine efforts to advance women's health by channeling energy into individualized optimization rather than systemic change.
The researchers are not calling for a ban. Instead, they propose a series of concrete steps. Regulators should strengthen protections for consumer and employee data and require greater transparency about how user information is collected, stored, and used. Clinicians should recommend apps to patients only when those apps meet stringent scientific standards—a bar most current offerings do not clear. There is also a need to regulate misleading marketing claims and to resist what the researchers describe as the commercial co-option of feminist language and rhetoric. Some of the most effective apps, they note, have marketed themselves using the language of women's empowerment and bodily autonomy, which can make them feel trustworthy even when the science is thin.
One avenue forward involves meeting people where they actually encounter this content. Most women and girls learn about cycle syncing through social media, not through their doctors. Tailoring health communications to those same platforms—building credible counter-narratives about hormones and menstrual health—might help shift trust toward more reliable sources. The researchers conclude by emphasizing that health practitioners, regulators, and the public all have a role to play in understanding and addressing the risks these consumer technologies pose to women's health. The apps are not going away. But the conversation about what they can actually do, and at what cost, is only beginning.
Citas Notables
The evidence that these digital tools can actually help in the management of menstrual conditions, boost health, and provide insights into exercise and nutritional needs is lacking— Katharine Lee and colleagues, The BMJ
Quieres la nota completa?
Lee el original en News-Medical ↗